BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system.

Cited by papers we hold 3

• The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease · 2018
  No notice
• Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer’s disease · 2014
  No notice
• Truncated and modified amyloid-beta species · 2014
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.